Suppr超能文献

toll 样受体、环境笼养和肺部菌群失调。

Toll-like receptors, environmental caging, and lung dysbiosis.

机构信息

Division of Pulmonary and Critical Care Medicine, University of Michigan Medical School, Ann Arbor, Michigan.

Department of Molecular, Cellular and Developmental Biology, University of Michigan, Ann Arbor, Michigan.

出版信息

Am J Physiol Lung Cell Mol Physiol. 2021 Aug 1;321(2):L404-L415. doi: 10.1152/ajplung.00002.2021. Epub 2021 Jun 23.

Abstract

Recent studies have implicated lung microbiota in shaping local alveolar immune responses. Toll-like receptors are major sensors of microbiota and determinants of local epithelial homeostasis. The impact of toll-like receptor deficiency on lung microbiota is unknown. To determine whether the absence of toll-like receptors results in altered lung microbiota or dysbiosis, we compared lung microbiota in wild-type and toll-like receptor-deficient experimental mice using 16S ribosomal RNA gene quantification and sequencing. We used a randomized environmental caging strategy to determine the impact of toll-like receptors on lung microbiota. Lung microbiota are detectable in toll-like receptor-deficient experimental mice and exhibit considerable variability. The lung microbiota of toll-like receptor-deficient mice are altered in community composition (PERMANOVA < 0.001), display reduced diversity ( test = 0.0075), and bacterial burden ( test = 0.016) compared with wild-type mice with intact toll-like receptors and associated signaling pathways. The lung microbiota of wild-type mice when randomized to cages with toll-like receptor-deficient mice converged with no significant difference in community composition (PERMANOVA > 0.05) after 3 wk of cohousing. The lung microbiome of toll-like receptor-deficient mice is distinct from wild-type mice and may be less susceptible to the effects of caging as an environmental variable. Our observations support a role for toll-like receptor signaling in the shaping of lung microbiota.

摘要

最近的研究表明,肺部微生物群在塑造局部肺泡免疫反应方面起着重要作用。Toll 样受体是微生物群的主要传感器,也是局部上皮细胞稳态的决定因素。Toll 样受体缺失对肺部微生物群的影响尚不清楚。为了确定 Toll 样受体缺失是否会导致肺部微生物群改变或失调,我们使用 16S 核糖体 RNA 基因定量和测序比较了野生型和 Toll 样受体缺陷型实验小鼠的肺部微生物群。我们采用随机环境笼养策略来确定 Toll 样受体对肺部微生物群的影响。在 Toll 样受体缺陷型实验小鼠中可检测到肺部微生物群,且具有相当大的可变性。与 Toll 样受体完整且相关信号通路正常的野生型小鼠相比,Toll 样受体缺陷型小鼠的肺部微生物群群落组成发生改变(PERMANOVA < 0.001),多样性降低( test = 0.0075),细菌负荷增加( test = 0.016)。当将野生型小鼠随机分配到 Toll 样受体缺陷型小鼠的笼子中时,经过 3 周的共笼,其群落组成没有显著差异(PERMANOVA > 0.05)。Toll 样受体缺陷型小鼠的肺部微生物组与野生型小鼠明显不同,并且可能对笼养作为环境变量的影响不太敏感。我们的观察结果支持 Toll 样受体信号在肺部微生物群形成中的作用。

相似文献

1
Toll-like receptors, environmental caging, and lung dysbiosis.
Am J Physiol Lung Cell Mol Physiol. 2021 Aug 1;321(2):L404-L415. doi: 10.1152/ajplung.00002.2021. Epub 2021 Jun 23.
2
Cage Environment Regulates Gut Microbiota Independent of Toll-Like Receptors.
Infect Immun. 2021 Aug 16;89(9):e0018721. doi: 10.1128/IAI.00187-21.
5
Lung and Gut Microbiota Changes Associated with Infection in Mouse Models of Cystic Fibrosis.
Int J Mol Sci. 2021 Nov 10;22(22):12169. doi: 10.3390/ijms222212169.
6
Respiratory dysbiosis and population-wide temporal dynamics in canine chronic bronchitis and non-inflammatory respiratory disease.
PLoS One. 2020 Jan 28;15(1):e0228085. doi: 10.1371/journal.pone.0228085. eCollection 2020.
7
Familial transmission rather than defective innate immunity shapes the distinct intestinal microbiota of TLR-deficient mice.
J Exp Med. 2012 Jul 30;209(8):1445-56. doi: 10.1084/jem.20120504. Epub 2012 Jul 23.
9
Traumatic Brain Injury in Mice Induces Acute Bacterial Dysbiosis Within the Fecal Microbiome.
Front Immunol. 2018 Nov 27;9:2757. doi: 10.3389/fimmu.2018.02757. eCollection 2018.
10
Involvement of toll-like receptor 5 in mouse model of colonic hypersensitivity induced by neonatal maternal separation.
World J Gastroenterol. 2022 Aug 7;28(29):3903-3916. doi: 10.3748/wjg.v28.i29.3903.

引用本文的文献

1
Expanding the use of circulating microbiome in fish: contrast between the gut and blood microbiome of .
ISME Commun. 2025 Jul 11;5(1):ycaf116. doi: 10.1093/ismeco/ycaf116. eCollection 2025 Jan.
3
Human matters in asthma: Considering the microbiome in pulmonary health.
Front Pharmacol. 2022 Dec 2;13:1020133. doi: 10.3389/fphar.2022.1020133. eCollection 2022.
4
Reply to Pantaleón García et al.
Am J Physiol Lung Cell Mol Physiol. 2022 Aug 1;323(2):L221-L222. doi: 10.1152/ajplung.00205.2022.
5
Minimizing caging effects in murine lung microbiome studies.
Am J Physiol Lung Cell Mol Physiol. 2022 Aug 1;323(2):L219-L220. doi: 10.1152/ajplung.00144.2022.
7
Toll-like receptors, innate immune system, and lung diseases: a vital trilateral association.
EXCLI J. 2022 Feb 25;21:519-523. doi: 10.17179/excli2022-4688. eCollection 2022.
8
Toll-Interacting Protein and Altered Lung Microbiota in Idiopathic Pulmonary Fibrosis.
Am J Respir Crit Care Med. 2022 Jul 15;206(2):224-227. doi: 10.1164/rccm.202111-2590LE.
9
Toll-like receptors: shapers of the pulmonary microbiome?
Am J Physiol Lung Cell Mol Physiol. 2021 Sep 1;321(3):L553-L554. doi: 10.1152/ajplung.00279.2021. Epub 2021 Aug 4.

本文引用的文献

2
Recent advances in understanding the ecology of the lung microbiota and deciphering the gut-lung axis.
Am J Physiol Lung Cell Mol Physiol. 2020 Oct 1;319(4):L710-L716. doi: 10.1152/ajplung.00360.2020. Epub 2020 Sep 2.
3
The evolving role of the lung microbiome in pulmonary fibrosis.
Am J Physiol Lung Cell Mol Physiol. 2020 Oct 1;319(4):L675-L682. doi: 10.1152/ajplung.00258.2020. Epub 2020 Sep 2.
4
Lung and gut microbiota are altered by hyperoxia and contribute to oxygen-induced lung injury in mice.
Sci Transl Med. 2020 Aug 12;12(556). doi: 10.1126/scitranslmed.aau9959.
5
Microbiome-derived inosine modulates response to checkpoint inhibitor immunotherapy.
Science. 2020 Sep 18;369(6510):1481-1489. doi: 10.1126/science.abc3421. Epub 2020 Aug 13.
6
Critical Relevance of Stochastic Effects on Low-Bacterial-Biomass 16S rRNA Gene Analysis.
mBio. 2020 Jun 9;11(3):e00258-20. doi: 10.1128/mBio.00258-20.
7
Toll-like Receptors and the Control of Immunity.
Cell. 2020 Mar 19;180(6):1044-1066. doi: 10.1016/j.cell.2020.02.041. Epub 2020 Mar 11.
9
Lung Microbiota Predict Clinical Outcomes in Critically Ill Patients.
Am J Respir Crit Care Med. 2020 Mar 1;201(5):555-563. doi: 10.1164/rccm.201907-1487OC.
10
The emergence of preclinical studies on the role of the microbiome in lung development and experimental animal models of bronchopulmonary dysplasia.
Am J Physiol Lung Cell Mol Physiol. 2020 Feb 1;318(2):L402-L404. doi: 10.1152/ajplung.00509.2019. Epub 2020 Jan 22.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验